Logos Global Management LP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
Logos Global Management LP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$40,467,750
+714.7%
1,975,000
+690.0%
5.40%
+698.7%
Q2 2023$4,967,500
-67.8%
250,000
-72.2%
0.68%
-69.4%
Q1 2023$15,417,000
+5.0%
900,000
+20.0%
2.21%
+28.4%
Q4 2022$14,677,500
+367.4%
750,000
+400.0%
1.72%
+174.2%
Q2 2020$3,140,000
+1320.8%
150,000
+848.8%
0.63%
+646.4%
Q1 2020$221,000
-95.7%
15,809
-92.9%
0.08%
-93.3%
Q4 2019$5,083,000223,3371.25%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders